Skip to main content
SpringerLink
Log in

Biologics major cost driver in AS and PsA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Greenberg JD, et al. Healthcare Resource Use and Direct Costs in Patients with Ankylosing Spondylitis and Psoriatic Arthritis in a Large US Cohort. The Journal of Rheumatology : 1 Dec 2015. Available from: URL: http://doi.org/10.3899/jrheum.150540

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Biologics major cost driver in AS and PsA. PharmacoEcon Outcomes News 743, 16 (2015). https://doi.org/10.1007/s40274-015-2681-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2681-x

Search

Navigation